Business Description
Beximco Pharmaceuticals Ltd
ISIN : US0885792061
Share Class Description:
BXMPY: DRCompare
Compare
Traded in other countries / regions
BXPHARMA.BangladeshBXP.UKR2WA.Germany IPO Date
2014-08-04Description
Beximco Pharmaceuticals Ltd is engaged in manufacturing and marketing a wide range of generic pharmaceutical formulation products, life-saving intravenous fluids, therapeutic nutrition products, and Active Pharmaceutical Ingredients. It manufactures various pharmaceutical products including oral contraceptives, hormones, steroids, anti-histamine, anti-fibrinolytic, cardiac, musculoskeletal, respiratory, vitamin & mineral supplements, women's health products, and others. The products of the company are sold in domestic and international markets. Key revenue accrues from local sales.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.18 | |||||
| Equity-to-Asset | 0.66 | |||||
| Debt-to-Equity | 0.16 | |||||
| Debt-to-EBITDA | 1.3 | |||||
| Interest Coverage | 6.93 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 3.37 | |||||
| Beneish M-Score | -2.36 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 15.3 | |||||
| 3-Year EBITDA Growth Rate | 17.1 | |||||
| 3-Year EPS without NRI Growth Rate | 9.1 | |||||
| 3-Year FCF Growth Rate | 1.1 | |||||
| 3-Year Book Growth Rate | 10.4 | |||||
| Future 3-5Y Total Revenue Growth Rate | 13.34 |
Momentum Rank
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.8 | |||||
| Quick Ratio | 0.72 | |||||
| Cash Ratio | 0.11 | |||||
| Days Inventory | 267.63 | |||||
| Days Sales Outstanding | 39.91 | |||||
| Days Payable | 71.05 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Dividend Growth Rate | 36.9 | |||||
| Shareholder Yield % | 9.11 |
Profitability Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 43.63 | |||||
| Operating Margin % | 18.23 | |||||
| Net Margin % | 11.83 | |||||
| ROE % | 8.49 | |||||
| ROA % | 5.42 | |||||
| ROIC % | 7.05 | |||||
| ROC (Joel Greenblatt) % | 10.5 | |||||
| ROCE % | 10.08 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 14.05 | |||||
| PE Ratio without NRI | 14.05 | |||||
| Shiller PE Ratio | 13.63 | |||||
| Price-to-Owner-Earnings | 45.31 | |||||
| PEG Ratio | 0.72 | |||||
| PS Ratio | 1.66 | |||||
| PB Ratio | 1.14 | |||||
| Price-to-Free-Cash-Flow | 19.97 | |||||
| Price-to-Operating-Cash-Flow | 13.58 | |||||
| EV-to-EBIT | 10.35 | |||||
| EV-to-EBITDA | 10.35 | |||||
| EV-to-Revenue | 1.85 | |||||
| EV-to-FCF | 22.25 | |||||
| Earnings Yield (Greenblatt) % | 9.66 | |||||
| FCF Yield % | 5.01 | |||||
| Forward Rate of Return (Yacktman) % | 12.58 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with GREY:BXMPY
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Beximco Pharmaceuticals Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | 0.07 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR ($) | 0 | ||
| 20-Day SMA ($) | 0 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range ($) | 0 - 0 | ||
| Shares Outstanding (Mil) | 446.11 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Beximco Pharmaceuticals Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Beximco Pharmaceuticals Ltd Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Beximco Pharmaceuticals Ltd Frequently Asked Questions
What is Beximco Pharmaceuticals Ltd(BXMPY)'s stock price today?
The current price of BXMPY is $0.00. The 52 week high of BXMPY is $0.00 and 52 week low is $0.00.
When is next earnings date of Beximco Pharmaceuticals Ltd(BXMPY)?
The next earnings date of Beximco Pharmaceuticals Ltd(BXMPY) is 2024-07-30 Est..
Does Beximco Pharmaceuticals Ltd(BXMPY) pay dividends? If so, how much?
Beximco Pharmaceuticals Ltd(BXMPY) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers